Page 13 - AIH-1-3
P. 13
Artificial Intelligence in Health AI in pharma: Embracing transformation
doi: 10.1016/j.cie.2021.107774 the literature. Pharmaceut Med. 2022;36(5):295-306.
4. Brodeur A, Gray D, Islam A, Bhuiyan S. A literature doi: 10.1007/s40290-022-00441-z
review of the economics of COVID‐19. J Econ Surv. 17. Association of the British Pharmaceutical Industry. Medicine
2021;35(4):1007-1044.
Lifecycle; 2021. Available from: https://www.abpi.org.uk/
doi: 10.1111/joes.12423 value-and-access/uk-medicine-pricing/medicine-lifecycle
[Last accessed on 2023 Jun 24].
5. Schwab K. The Fourth Industrial Revolution. New York:
Portfolio Penguin; 2017. 18. Paul D, Sanap G, Shenoy S, Kalyane D, Kalia K, Tekade RK.
Artificial intelligence in drug discovery and development.
6. Russell S, Norvig P. Artificial Intelligence: A Modern
Approach. 4 ed. London: Pearson; 2022. Drug Discov Today. 2021;26(1):80-93.
th
doi: 10.2174/1872208316666220802151129
7. Selvaraj C, Chandra I, Singh S. Artificial intelligence and
machine learning approaches for drug design: Challenges 19. Askin S, Burkhalter D, Calado G, El Dakrouni S. Artificial
and opportunities for the pharmaceutical industries. Mol intelligence applied to clinical trials: Opportunities and
Divers. 2021;26:1893-1913. challenges. Health Technol (Berl). 2023;13(2):203-213.
doi: 10.1007/s11030-021-10326-z doi: 10.1007/s12553-023-00738-2
8. Kulkov I. The role of artificial intelligence in business 20. Harrer S, Shah P, Antony B, Hu J. Artificial intelligence for
transformation: A case of pharmaceutical companies. clinical trial design. Trends Pharmacol Sci. 2019;40(8):577-591.
Technol Soc. 2021;66:101629.
doi: 10.1016/j.tips.2019.05.005
doi: 10.1016/j.techsoc.2021.101629
21. Hockings JK, Pasternak AL, Erwin AL, Mason N, Eng C,
9. Bodenheimer T, Sinsky C. From triple to quadruple aim: Hicks JK. Pharmacogenomics: An evolving clinical tool for
Care of the patient requires care of the provider. Ann Fam precision medicine. Cleve Clin J Med. 2020;87(2):91-99.
Med. 2014;12(6):573-576.
doi: 10.3949/ccjm.87a.19073
doi: 10.1370/afm.1713
22. CNBC. Google Cloud Launches A.I.-Powered Tools to
10. Kelly BS, Judge C, Bollard SM, et al. Radiology artificial Accelerate Drug Discovery, Precision Medicine; 2023.
intelligence: A systematic review and evaluation of methods Available from: https://www-cnbc-com.cdn.ampproject.
(RAISE). Eur Radiol. 2022;32(11):7998-8007. org/c/s/www.cnbc.com/amp/2023/05/16/google-cloud-
launches-ai-tools-to-accelerate-drug-discovery.html [Last
doi: 10.1007/s00330-022-08784-6
accessed on 2023 Jun 13].
11. Secinaro S, Calandra D, Secinaro A, Muthurangu V, Biancone P.
The role of artificial intelligence in healthcare: A structured 23. Euchner J. Generative AI. Res Manage. 2023;66(3):71-74.
literature review. BMC Med Inform Decis Mak. 2021;21:125. doi: 10.1080/08956308.2023.2188861
doi: 10.1186/s12911-021-01488-9 24. Ebert C, Louridas P. Generative AI for software practitioners.
IEEE Softw. 2023;40(4):30-38.
12. Association of the British Pharmaceutical Industry. Code
of Practice for the Pharmaceutical Industry 2021; 2021. doi: 10.1109/MS.2023.3265877
Available from: https://www.abpi.org.uk/publications/code- 25. McKinsey. The Economic Potential of Generative AI: The
of-practice-for-the-pharmaceutical-industry-2021 [Last Next Productivity Frontier; 2023. Available from: https://
accessed on 2023 May 01].
www.mckinsey.com/capabilities/mckinsey-digital/our-
13. EY. EY Smart Reviewer; 2023. Available from: https://www. insights/the-economic-potential-of-generative-ai-the-next-
ey.com/en_uk/life-sciences/smart-reviewer [Last accessed productivity-frontier [Last accessed on 2023 Jun 15].
on 2023 Jun 15].
26. Forbes. Who’s Winning the Chatbot Race? These
14. Lucas S, Ailani J, Smith TR, Abdrabboh A, Xue F, Navetta MS. Companies -from Meta to Alibaba -Have All Introduced
Pharmacovigilance: Reporting requirements throughout a AI-Powered Programs; 2023. Available from: https://www.
product’s lifecycle. Ther Adv Drug Saf. 2022;13:1-16. forbes.com/sites/ariannajohnson/2023/04/13/whos-
winning-the-chatbot-race-these-companies--from-meta-
doi: 10.1177/20420986221125006
to-alibaba-have-all-introduced-ai-powered-programs [Last
15. World Health Organization. The Importance of accessed on 2023 Jun 13].
Pharmacovigilance: Safety Monitoring of Medicinal Products;
2023. Available from: https://www.who.int/publications/i/ 27. Rosario A, Moniz L, Cruz R. Data science applied to
item/10665-42493 [Last accessed on 2023 Jun 18]. marketing. J Inform Sci Eng. 2021;37(5):1067-1081.
doi: 10.6688/JISE.202109_37(5).0006
16. Salas M, Petracek J, Yalamanchili P, et al. The use of artificial
intelligence in pharmacovigilance: A systematic review of 28. Verma S, Sharma R, Deb S, Maitra D. Artificial intelligence in
Volume 1 Issue 3 (2024) 7 doi: 10.36922/aih.2973

